Brokerages Set Oscar Health, Inc. (NYSE:OSCR) Target Price at $21.56

Oscar Health, Inc. (NYSE:OSCR) has earned a consensus rating of “Hold” from the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, two have given a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $21.56.

Several research analysts have recently weighed in on the stock. Jefferies Financial Group began coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target on the stock. UBS Group started coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Finally, Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th.

Oscar Health Stock Up 5.6 %

OSCR stock opened at $14.96 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a 50-day moving average of $14.96 and a two-hundred day moving average of $16.85. Oscar Health has a 12 month low of $10.45 and a 12 month high of $23.79. The company has a market cap of $3.70 billion, a price-to-earnings ratio of -249.29 and a beta of 1.70.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business’s quarterly revenue was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.29) EPS. As a group, analysts forecast that Oscar Health will post -0.01 earnings per share for the current fiscal year.

Insider Transactions at Oscar Health

In related news, CAO Victoria Baltrus sold 8,078 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the transaction, the chief accounting officer now directly owns 146,036 shares in the company, valued at $2,640,330.88. This trade represents a 5.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Vice Chairman Joshua Kushner purchased 276,040 shares of the business’s stock in a transaction on Monday, November 11th. The shares were acquired at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the purchase, the insider now directly owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. KBC Group NV raised its stake in shares of Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after acquiring an additional 1,328 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in Oscar Health in the 2nd quarter valued at about $78,000. Quest Partners LLC purchased a new position in shares of Oscar Health in the 2nd quarter valued at about $93,000. Optimum Investment Advisors acquired a new position in shares of Oscar Health during the third quarter worth about $142,000. Finally, Amalgamated Bank increased its stake in shares of Oscar Health by 27.7% during the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.